Devices › Device types
FDA product code MPN · class 2 · General, Plastic Surgery
Tissue adhesive for the topical approximation of skin: medical device reports filed with FDA
3,646 reports carry this product code, 1999–2026; 9 brands with a page.
- 3,646
- reports with this product code
- 0% of all MAUDE reports
- 236
- reports, 12 months to August 2026
- 241 in the 12 months before
- 34.1%
- classified as malfunction
- 62.3% across all reports
- 0.2%
- classified as death, as reported
- 0.9% across all reports
Product code MPN is FDA's classification for "Tissue adhesive for the topical approximation of skin" (general, Plastic Surgery panel), a class 2 device. 3,646 medical device reports carry this product code, 0% of the MAUDE database, from February 1999 to August 2026.
236 reports arrived in the 12 months to August 2026, close to the 241 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (54.9%), malfunction (34.1%) and other (10.1%). 9 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Dermabond Advanced 0 7ml - 12ea | 557 | 59 | 0% | 36.4% |
| Dermabond Topical Skin Adhesive | 476 | 0 | 0.4% | 7.1% |
| Dermabond Advanced Topical Skin Adhesive | 371 | 0 | 0% | 40.4% |
| Histoacryl Blue 0 5ml | 277 | 0 | 0% | 99.6% |
| Dermabond Unknown Product | 193 | 15 | 0.5% | 2.9% |
| DermaBond Advanced | 179 | 54 | 0% | 25.1% |
| Liquiband Exceed | 158 | 8 | 0% | 1.3% |
| Dermabond | 149 | 1 | 0% | 6.5% |
| Prineo Skin Closure System | 49 | 0 | 0% | 2.4% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Ethicon | 763 | 20.9% |
| B Braun Surgical | 534 | 14.6% |
| Cryolife | 11 | 0.3% |
| Ethicon Endo Surgery Cincinnati | 7 | 0.2% |
| United States Surgical | 4 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Reactiona reaction, type not specified | 343 | 9.4% |
| Other (for use when an appropriate device code cannot be identified) | 328 | 9% |
| Breakthe device broke | 269 | 7.4% |
| Fluid/blood leak | 204 | 5.6% |
| Patient device interaction problem | 161 | 4.4% |
| Patient-device incompatibilitythe device did not suit the patient | 143 | 3.9% |
| Misapplication | 112 | 3.1% |
| Mechanical problema mechanical problem | 96 | 2.6% |
| Insufficient device problem information | 90 | 2.5% |
| Material integrity problema problem with the device material | 89 | 2.4% |
| Device contaminated during manufacture or shipping | 82 | 2.2% |
| Gel leak | 64 | 1.8% |
| Crackthe device cracked | 59 | 1.6% |
| Partial blockage | 38 | 1% |
| Device operates differently than expectedthe device behaved unexpectedly | 37 | 1% |
| Migration or expulsion of device | 33 | 0.9% |
| Leak/splashthe device leaked | 28 | 0.8% |
| Packaging problem | 24 | 0.7% |
| Failure to adhere or bond | 21 | 0.6% |
| Replace | 21 | 0.6% |
Questions about tissue adhesive for the topical approximation of skin reports
What is product code MPN?
FDA's classification code for "Tissue adhesive for the topical approximation of skin", class 2, reviewed by the general, Plastic Surgery panel. Every device report carries the product code of the device involved.
How many reports carry this code?
3,646 reports through August 2026, 236 of them in the latest 12 months.
Which brands appear most often?
Dermabond Advanced 0 7ml - 12ea (557), Dermabond Topical Skin Adhesive (476), Dermabond Advanced Topical Skin Adhesive (371), Histoacryl Blue 0 5ml (277) and Dermabond Unknown Product (193). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.